(URGN) Urogen Pharma complete technical analysis [charts+indicators] | Buy/Sell Urogen Pharma | (URGN) share price targets
Complete technical analysis of Urogen Pharma (URGN) by charts plus indicators, forecast predictions and share price targets for Urogen Pharma (URGN)
Urogen Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-29 View latest technical analysis
10 day averaged volume of Urogen Pharma is 332864
| Date | Daily Closing Price | Open | High | Low | Volume |
| 29 Wed May 2024 | 13.26 | 13.40 | 13.57 | 13.12 | 1.135 times |
| 28 Tue May 2024 | 13.61 | 13.00 | 13.75 | 12.95 | 0.904 times |
| 23 Thu May 2024 | 12.85 | 13.31 | 13.36 | 12.57 | 0.768 times |
| 22 Wed May 2024 | 13.31 | 13.22 | 13.51 | 13.07 | 0.694 times |
| 21 Tue May 2024 | 13.27 | 12.87 | 13.58 | 12.87 | 0.675 times |
| 20 Mon May 2024 | 12.91 | 13.30 | 13.46 | 12.84 | 0.617 times |
| 17 Fri May 2024 | 13.22 | 13.22 | 13.35 | 13.04 | 0.697 times |
| 16 Thu May 2024 | 13.21 | 13.72 | 13.72 | 13.19 | 0.623 times |
| 15 Wed May 2024 | 13.78 | 13.13 | 14.05 | 13.13 | 1.855 times |
| 14 Tue May 2024 | 12.97 | 12.74 | 13.16 | 12.60 | 1.447 times |
My analysis of stock is bearish for shortterm, and stock might move down till 12.9 or till 12.4. Use a stoploss of 13.43 and if the stock hits stoploss, then it can shoot up till 13.91
Share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Target | 10.60 |
| Downside Target | 12.25 |
| Downside Target | 12.95 |
| Upside Target | 13.40 |
| Upside Target | 14.70 |
| Upside Target | 14.89 |
| Upside Target | 15.40 |
| Upside Target | 15.50 |
| Upside Target | 16.45 |
| Upside Target | 18.63 |
| Upside Target | 19.87 |
Intraday share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Intraday Target | 12.89 |
| Downside Intraday Target | 12.52 |
| Upside Intraday Target | 13.69 |
| Upside Intraday Target | 14.12 |
| Upside Intraday Target | 13.32 |
Weekly technical analysis of Urogen Pharma (URGN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 29 Wed May 2024 | 13.26 | 13.00 | 13.75 | 12.95 | 0.74 times |
| 23 Thu May 2024 | 12.85 | 13.30 | 13.58 | 12.57 | 0.434 times |
| 17 Fri May 2024 | 13.22 | 10.90 | 14.05 | 10.60 | 1.331 times |
| 10 Fri May 2024 | 12.74 | 14.66 | 14.89 | 12.25 | 1.727 times |
| 03 Fri May 2024 | 14.30 | 14.22 | 14.70 | 13.78 | 1.005 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Urogen Pharma (URGN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 29 Wed May 2024 | 13.26 | 14.06 | 14.89 | 10.60 | 0.903 times |
| 30 Tue Apr 2024 | 13.82 | 14.75 | 15.50 | 12.37 | 0.752 times |
| 28 Thu Mar 2024 | 15.00 | 17.32 | 18.63 | 13.83 | 1.155 times |
| 29 Thu Feb 2024 | 18.33 | 15.76 | 19.87 | 15.40 | 1.398 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Urogen Pharma (URGN)
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Urogen Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Urogen Pharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.29 and Urogen Pharma (URGN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Urogen Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Urogen Pharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.29 and Urogen Pharma (URGN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.